Top-News

Barinthus Biotherapeutics Aktie News

Aktie
WKN:  A3CN5Q ISIN:  US91864C1071 US-Symbol:  BRNS Branche:  Biotechnologie Land:  Großbritannien
0,615 €
-0,04 €
-6,11%
22:43:43 Uhr
Depot/Watchlist
Marktkapitalisierung *
27,52 Mio. €
Streubesitz
42,21%
KGV
-0,77
Index-Zuordnung
-

Barinthus Biotherapeutics News

19.11.25 - PR Newswire
Halper Sadeh LLC Encourages BRNS, FITB, ADVM, HBAN Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC Encourages BRNS, FITB, ADVM, HBAN Shareholders to Contact the Firm to Discuss Their Rights PR Newswire
19.11.25 - PR Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-CMA, HFWA, BRNS, and FITB
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-​CMA, HFWA, BRNS, and FITB PR Newswire
12.11.25 - PR Newswire
Halper Sadeh LLC Encourages NIC, AKRO, BRNS Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC Encourages NIC, AKRO, BRNS Shareholders to Contact the Firm to Discuss Their Rights PR Newswire
10.11.25 - PR Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger-CRTAF, AKRO, NIC, and BRNS
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger-​CRTAF, AKRO, NIC, and BRNS PR Newswire
24.10.25 - PR Newswire
ChemDiv Continues R&D Services Support for Clywedog Therapeutics Following Merger with Barinthus Therapeutics
ChemDiv Continues R&D Services Support for Clywedog Therapeutics Following Merger with Barinthus Therapeutics PR Newswire
16.10.25 - PR Newswire
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates SWKH, ETNB, BRNS, VRNT on Behalf of Shareholders
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates SWKH, ETNB, BRNS, VRNT on Behalf of Shareholders PR Newswire
07.10.25 - PR Newswire
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates ETNB, TRML, CORZ, BRNS on Behalf of Shareholders
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates ETNB, TRML, CORZ, BRNS on Behalf of Shareholders PR Newswire
30.09.25 - GlobeNewswire
Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases
GERMANTOWN, MD and ALTRINCHAM, UK, Sept. 30, 2025 (GLOBE NEWSWIRE) --

Newssuche

Videos

newspaper
10:20 Uhr +1,73%
Technical Trading: Gold Zukauf Chance
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »